Pharma Industry Seeks Incentives and Conducive Policies in Interim Budget 2024
Pharma Industry The pharmaceutical industry in India is gearing up for the interim Budget 2024, and it has expressed its need for conducive policies that provide benefits in terms of both direct and indirect taxes. With the industry projected to reach a market size of $400–450 billion by 2047, there is also a strong demand for incentives to promote research and development. In a statement, Sudarshan Jain, the Secretary General …